Eratrectinib

Eratrectinib (Example 1) is a Trk inhibitor. Eratrectinib can be studied in research for tropomyosin receptor kinase-related diseases and cancers[1].

Product Specifications

CAS Number

[2396516-98-4]

UNSPSC

12352005

Target

Trk Receptor

Related Pathways

Neuronal Signaling; Protein Tyrosine Kinase/RTK

Field of Research

Cancer

Smiles

FC(C=C1[C@]2([H])N(CCC2)C3=NC4=C5C=NN4C=C3)=CN=C1CCN(C6CC6)NC5=O

Molecular Formula

C21H22FN7O

Molecular Weight

407.44

References & Citations

[1]Yong Wu, et al., Pyrazolo[1,5-a]pyrimidine derivatives as tropomyosin receptor kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. WO2019233461A1.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-98898APC 0.1 mL

Rabbit Polyclonal HNF-4 gamma/NR2A2 Antibody [Allophycocyanin]

Ask

View Details

FAB4705F 0.1 mL

Mouse Monoclonal FCRLB/FCRY Antibody (454217) [FITC]

Ask

View Details

039263 200 µL

ODF3, CT (ODF3, SHIPPO1, TISP50, Outer dense fiber protein 3, Outer dense fiber of sperm tails protein 3, Sperm tail protein SHIPPO 1, Transcript induced in spermiogenesis protein 50)

Ask

View Details

bsm-62972R-BF488-01 20 µL

RPS6KB2 Recombinant Antibody, AbBy Fluor™ 488 Conjugated

Ask

View Details

bsm-62972R-BF488-02 100 µL

RPS6KB2 Recombinant Antibody, AbBy Fluor™ 488 Conjugated

Ask

View Details